- Home
- ACRE vs MXCT Comparison
ACRE vs MXCT Comparison
Compare ACRE & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRE
- MXCT
- Stock Information
- Founded
- ACRE 2011
- MXCT 1999
- Country
- ACRE United States
- MXCT United States
- Employees
- ACRE N/A
- MXCT N/A
- Industry
- ACRE Real Estate Investment Trusts
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ACRE Real Estate
- MXCT Health Care
- Exchange
- ACRE Nasdaq
- MXCT Nasdaq
- Market Cap
- ACRE 388.6M
- MXCT 398.3M
- IPO Year
- ACRE 2012
- MXCT 2021
- Fundamental
- Price
- ACRE $7.16
- MXCT $3.45
- Analyst Decision
- ACRE Hold
- MXCT Strong Buy
- Analyst Count
- ACRE 7
- MXCT 3
- Target Price
- ACRE $7.10
- MXCT $8.67
- AVG Volume (30 Days)
- ACRE 442.3K
- MXCT 599.5K
- Earning Date
- ACRE 11-07-2024
- MXCT 11-06-2024
- Dividend Yield
- ACRE 13.95%
- MXCT N/A
- EPS Growth
- ACRE N/A
- MXCT N/A
- EPS
- ACRE N/A
- MXCT N/A
- Revenue
- ACRE $39,423,000.00
- MXCT $45,599,000.00
- Revenue This Year
- ACRE N/A
- MXCT N/A
- Revenue Next Year
- ACRE $0.48
- MXCT $21.59
- P/E Ratio
- ACRE N/A
- MXCT N/A
- Revenue Growth
- ACRE N/A
- MXCT 19.85
- 52 Week Low
- ACRE $6.25
- MXCT $3.17
- 52 Week High
- ACRE $11.24
- MXCT $5.55
- Technical
- Relative Strength Index (RSI)
- ACRE 60.42
- MXCT 44.48
- Support Level
- ACRE $6.86
- MXCT $3.17
- Resistance Level
- ACRE $7.15
- MXCT $3.61
- Average True Range (ATR)
- ACRE 0.24
- MXCT 0.25
- MACD
- ACRE 0.05
- MXCT -0.01
- Stochastic Oscillator
- ACRE 81.25
- MXCT 28.93
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.